Dr. Bankole Johnson - 23 May 2023 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ Dr. Bankole Johnson
Issuer symbol
ADIL
Transactions as of
23 May 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 07:52:35 UTC
Previous filing
25 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option Award $0 +40,000 $0.000000 40,000 23 May 2023 Common Stock 40,000 $0.3025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.